Theryte of Liverpool (WO 99/42835) describes a test to determine which
chemotherapy agent is best for treating a particular tumour: chemotherapy with
cis-platinum or taxanes such as taxol. Theryte’s trick is to fluorescently label
a tumour biopsy sample with antibodies against the telltale cyclin D1 protein.
If laser light highlights an abundance of D1, taxane treatment is recommended;
if D1 is absent, cis-platinum is prescribed. This, says Theryte, saves
money—and lives—by quickly finding the most appropriate treatment.
More from New Scientist
Explore the latest news, articles and features
Technology
Feeding our books into generative AI risks creating a cultural void
91É«Ç鯬
Technology
Quantum computing may be facing a replication crisis
News
Technology
Rogue hacking AIs have changed the cybersecurity landscape
News
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Popular articles
Trending New Scientist articles